Kazem M Azadzoi Selected Research

Kazem M Azadzoi Research Topics

Disease

16	Ischemia 12/2023 - 05/2003
7	Hypoxia (Hypoxemia) 11/2021 - 08/2007
5	Erectile Dysfunction 11/2013 - 01/2002
4	Atherosclerosis 12/2022 - 08/2003
2	Overactive Urinary Bladder (Overactive Bladder) 01/2021 - 01/2010
2	Infections 04/2017 - 03/2016
2	Neoplasms (Cancer) 02/2017 - 01/2017
2	Nocturia 05/2015 - 03/2015
2	Fibrosis (Cirrhosis) 11/2011 - 07/2005
1	Kidney Neoplasms (Kidney Cancer) 02/2017
1	Inflammation (Inflammations) 02/2017
1	Glioma (Gliomas) 01/2017
1	Hyperglycemia 05/2016
1	Obstructive Sleep Apnea 05/2015
1	Sleep Wake Disorders 03/2015
1	Hyperemia 10/2002

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 12/2023 - 05/2003
4	Amino Acids FDA Link 12/2023 - 02/2017
4	Nerve Growth Factor (NGF)IBA 11/2021 - 08/2007
3	Contractile ProteinsIBA 12/2023 - 01/2021
3	Superoxide DismutaseIBA 02/2017 - 01/2010
3	Oxygen (Dioxygen)IBA 05/2015 - 05/2004
2	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2022 - 05/2016
2	Caspase 3 (Caspase-3)IBA 01/2022 - 11/2021
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2021 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2021 - 11/2011
2	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2021 - 11/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2017 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 05/2015
2	AntioxidantsIBA 10/2011 - 07/2005
2	Aldehyde Reductase (Aldose Reductase)IBA 02/2010 - 01/2010
2	Free RadicalsIBA 01/2010 - 08/2007
1	ProteomeIBA 12/2023
1	cyclopropapyrroloindoleIBA 12/2022
1	Adenosine Monophosphate (AMP)IBA 11/2021
1	MAP Kinase Kinase Kinase 5IBA 11/2021
1	Protein Kinases (Protein Kinase)IBA 11/2021
1	ApolipoproteinsIBA 01/2021
1	AICA ribonucleotide (ZMP)IBA 01/2021
1	Serine (L-Serine)FDA Link 04/2017
1	Serine O-AcetyltransferaseIBA 04/2017
1	Superoxides (Superoxide)IBA 02/2017
1	ManganeseIBA 02/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	glucose-regulated proteinsIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 05/2016
1	InterferonsIBA 03/2016
1	Antiviral Agents (Antivirals)IBA 03/2016
1	Pathogen-Associated Molecular Pattern MoleculesIBA 03/2016
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2016
1	Muscarinic M2 ReceptorIBA 01/2016
1	salicylhydroxamic acid (SHAM)IBA 05/2015
1	Indicators and Reagents (Reagents)IBA 03/2015
1	Phosphodiesterase InhibitorsIBA 11/2013
1	3-nitrotyrosineIBA 02/2010
1	TachykininsIBA 05/2008
1	8-epi-prostaglandin F2alphaIBA 07/2005
1	IsoprostanesIBA 07/2005
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 05/2004
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 05/2004
1	CholesterolIBA 08/2003
1	Leukotriene B4IBA 05/2003
1	Thromboxane A2 (A2, Thromboxane)IBA 05/2003
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2003
1	Lipoxygenase (Lipoxygenase-1)IBA 05/2003
1	Carbachol (Carbastat)FDA Link 05/2003
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 05/2003
1	LeukotrienesIBA 05/2003
1	Arginine (L-Arginine)FDA Link 10/2002
1	Endothelin A ReceptorIBA 01/2002

Therapy/Procedure

2	General Anesthesia 01/2017 - 01/2016
2	Therapeutics 07/2005 - 08/2003
1	Catheters 01/2021